Obesity Could Be Pharma’s Biggest Blockbuster

As the popularity of drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro grow rapidly, patient testimonies have focused not only on the dramatic weight-loss effect but also on how quickly many seem to regain weight if they stop taking the injections. Investors can get excited by a product whose target market is so large (apparently more than 40 percent of American adults are obese) and the medicine must be taken indefinitely.

The Covid-19 Isn’t the Only Reason People Are Fat

Not all countries have the same eating habits, but the ones that have abundant food. over-eat and under-exercise. Over-eating in the United States was proven by research by Brian Wansink. His research was compelling (if memory serves we bought his book during a Cornell reunion), the Wall Street Journal referenced him saying that overweight waiters may inspire restaurant customers to eat and drink more. Unfortunately, Wansink was cheating on his research to make it more newsworthy. The Wall Street Journal’s OVERHEAD column did some pizza research that showed the largest pizza-makers sold a lot more during the COVID. But there is also the good news that scientists found that the coronavirus attacks fat tissue. And you are not alone.